Found 17 matching trials
Study of Efficacy and Safety of Fingolimod (Gilenya) 0.5 mg in Chinese Patients With Relapsing Multiple Sclerosis (RMS) Patients PHASE4 The main purpose of this study was to assess the efficacy and safety of 0.5...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Fingolimod for Type 2 Diabetes Mellitus PHASE4 The aim of this study is to explore the efficacy and safety of Fingoland in...
Show More Location
Department of Neurology, General Hospital of Northern Theater Command
Learn More & Join Trial
Safety and Tolerability of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis PHASE3 This 4 month, open-label study will evaluate the safety and tolerability of...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Efficacy and Safety of FTY720 for Acute Stroke PHASE2 Stroke is one of the main severe disease of public health importance. Incre...
Show More Location
Tianjin Medical University General Hospital
Learn More & Join Trial
Evaluation of the Autonomic Nervous System During First-dosing With 0.5mg of Fingolimod (Gilenya) in Patients With Relapsing-remitting MS PHASE4 This study is designed to primarily evaluate the impact of Gilenya (Fingoli...
Show More Location
Cantonal Hospital St. Gallen
Learn More & Join Trial
Gilenya in Amyotrophic Lateral Sclerosis (ALS) PHASE2 The purpose of this study is to determine whether Gilenya, also known as fi...
Show More Location
University of California, Irvine
Learn More & Join Trial
This Was an Open-label, Single-arm Extension Study (CFTY720D2306E1) to a Double-blind, Randomized Multicenter, Placebo-controlled, Parallel-group Core Study (CFTY720D2306) in PPMS. PHASE3 The purpose of this study is to evaluate whether FTY720 is effective in del...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
A 12 -Month, Open-label, Multi-center Study to Explore the Health Outcomes of FTY720 PHASE4 The study will assess the patients' satisfaction of treatment after 12 mont...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Fingolimod (FTY720) in Acute Demyelinating Optic Neuritis (ADON) PHASE2 To evaluate the efficacy and safety of fingolimod 0.5mg versus placebo in p...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Long-term, Open-label, Multicenter Study Assessing Long-term Cardiovascular Risks PHASE4 This study will evaluate if patients who had a serious cardiovascular event...
Show More Location
Novartis Investigative Site
Learn More & Join Trial